Word

IVEXSOL PROCL

Status

Pending

Status Code

630

Status Date

Friday, April 5, 2024

Serial Number

98486369

Mark Type

4000

Filing Date

Friday, April 5, 2024

Trademark Owner History

iVexSol Inc.

Classifications

40 Treatment of materials in the nature of cells, viruses, and biological membranes to obtain carriers for gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Treatment of materials, namely, the conversion of cells, viruses, and biological membranes into biochemical preparations; Custom manufacturing of biological substances, materials, and preparations; Custom manufacturing of cells, viruses, viral vectors, viral constructs and biological membranes; Manufacturing and processing for others of cells, viruses, viral vectors, viral constructs and biological membranes for third parties; Manufacturing and processing for others of gene therapy products, pharmaceuticals, biopharmaceuticals, biological preparations and vaccines; Processing of biological and generic material for others

1 Biological materials being viral vectors for scientific and industrial use and for use in the manufacture and development of pharmaceutical and biopharmaceutical preparations; biological preparations for scientific and industrial use; Carriers for biologically active compounds, namely, chemical and biological preparations for use in the delivery of biologically active compounds, for scientific and general industrial manufacturing use; Viruses, viral vectors and viral constructs being biological preparations for scientific and industrial use; Cells and biological membranes being a biological preparation for scientific and industrial use; Carriers for biologically active compounds, namely, chemical and biological preparations for use in the delivery of biologically active compounds for use in industry and the manufacture of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Chemical preparations for scientific and industrial use; Biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Cells and biological membranes being biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Viruses, viral vectors being vector viruses and viral constructs being biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines

Trademark Events

Apr 5, 2024

New Application Entered